Skip to content

Court Scrutinises Corporate Hospital Pharmacies Over Inflated Drug Bills

By News Analysis India · · 1 min read

During the same session, the Supreme Court turned its attention to corporate hospitals that force patients to procure medicines exclusively from their in‑house pharmacies. Justice Mehta observed that patients are often denied the option to buy drugs from external chemists, leading to higher out‑of‑pocket expenditures.

By insisting on internal procurement, hospitals effectively capture the markup between the low PTR price and the inflated MRP charged to patients. This practice, the Court noted, amounts to exploitation of vulnerable cancer patients who are already burdened by the disease.

The bench questioned the legality of such practices under consumer protection laws and urged the government to examine whether existing regulations on hospital pharmacy pricing are being violated.

The matter has been scheduled for a follow‑up hearing on October 12, giving the Centre a deadline to present its stand on the issue.